Ligation of 2', 3'-cyclic phosphate RNAs for the identification of microRNA binding sites.


Journal

FEBS letters
ISSN: 1873-3468
Titre abrégé: FEBS Lett
Pays: England
ID NLM: 0155157

Informations de publication

Date de publication:
01 2021
Historique:
received: 07 07 2020
revised: 27 09 2020
accepted: 08 10 2020
pubmed: 29 10 2020
medline: 16 7 2021
entrez: 28 10 2020
Statut: ppublish

Résumé

Identifying the targetome of a microRNA is key for understanding its functions. Cross-linking and immunoprecipitation (CLIP) methods capture native miRNA-mRNA interactions in cells. Some of these methods yield small amounts of chimeric miRNA-mRNA sequences via ligation of 5'-phosphorylated RNAs produced during the protocol. Here, we introduce chemically synthesized microRNAs (miRNAs) bearing 2'-, 3'-cyclic phosphate groups, as part of a new CLIP method that does not require 5'-phosphorylation for ligation. We show in a system that models miRNAs bound to their targets, that addition of recombinant bacterial ligase RtcB increases ligation efficiency, and that the transformation proceeds via a 3'-phosphate intermediate. By optimizing the chemistry underlying ligation, we provide the basis for an improved method to identify miRNA targetomes.

Identifiants

pubmed: 33113149
doi: 10.1002/1873-3468.13976
pmc: PMC7894349
doi:

Substances chimiques

Bacterial Proteins 0
Cross-Linking Reagents 0
MicroRNAs 0
RNA, Messenger 0
Recombinant Proteins 0
Ligases EC 6.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-240

Informations de copyright

© 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

Nat Commun. 2015 Nov 25;6:8864
pubmed: 26602609
Cell Mol Life Sci. 2012 Aug;69(16):2657-70
pubmed: 22426497
J Bacteriol. 2016 Mar 31;198(8):1294-304
pubmed: 26858100
Genet Sel Evol. 2016 Apr 04;48:31
pubmed: 27044644
Cell. 2006 Oct 6;127(1):71-84
pubmed: 17018278
Nat Struct Mol Biol. 2018 Nov;25(11):1019-1027
pubmed: 30297778
Nucleic Acids Res. 2012 Sep 1;40(17):8558-67
pubmed: 22730297
J Biol Chem. 2004 Jul 23;279(30):31337-47
pubmed: 15084599
Elife. 2015 Aug 12;4:
pubmed: 26267216
Mol Cell. 2007 Jul 6;27(1):91-105
pubmed: 17612493
J Biol Chem. 2011 Sep 2;286(35):30253-7
pubmed: 21757685
J Mol Evol. 1973 Nov 27;2(4):303-16
pubmed: 4377773
Proc Natl Acad Sci U S A. 1985 Feb;82(3):684-8
pubmed: 3856222
Chimia (Aarau). 2019 May 29;73(6):368-373
pubmed: 31118118
Wiley Interdiscip Rev Dev Biol. 2016 May-Jun;5(3):311-62
pubmed: 26950183
Science. 2011 Feb 11;331(6018):760-4
pubmed: 21311021
Cell. 2013 Apr 25;153(3):654-65
pubmed: 23622248
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6072-7
pubmed: 22474365
Biochemistry. 1977 Feb 8;16(3):493-8
pubmed: 189802
Nucleic Acids Res. 1983 Mar 11;11(5):1405-18
pubmed: 6828385
Methods. 2012 Oct;58(2):94-105
pubmed: 22926237
Proc Natl Acad Sci U S A. 1975 Jan;72(1):122-6
pubmed: 1090929
Mol Cell. 2007 Jun 8;26(5):745-52
pubmed: 17540599
Dokl Biochem Biophys. 2005 Mar-Apr;401:163-6
pubmed: 15999828
Cancer Lett. 2016 Mar 1;372(1):137-46
pubmed: 26739063
J Biol Chem. 2011 Mar 11;286(10):7727-31
pubmed: 21224389
Cell. 2002 Sep 6;110(5):563-74
pubmed: 12230974
Science. 2014 Oct 31;346(6209):608-13
pubmed: 25359968
Mol Cell. 2010 Jun 25;38(6):789-802
pubmed: 20620952
Mol Cell. 2018 Feb 1;69(3):354-369
pubmed: 29395060
Genome Biol. 2014 Mar 14;15(3):R51
pubmed: 24629056
Science. 1976 Apr 2;192(4234):53-4
pubmed: 1257755
RNA. 2010 Mar;16(3):621-31
pubmed: 20075163
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Front Genet. 2018 Nov 27;9:562
pubmed: 30538719
Mol Cell. 2007 Jun 8;26(5):731-43
pubmed: 17540598
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):10010-5
pubmed: 21610164
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15235-40
pubmed: 22949672
Cell. 2010 Apr 2;141(1):129-41
pubmed: 20371350
Cell. 1983 Feb;32(2):547-57
pubmed: 6186399
DNA Cell Biol. 2013 Dec;32(12):699-707
pubmed: 24050776
Mol Cell. 2014 Jun 19;54(6):1042-1054
pubmed: 24857550
FEBS Lett. 2018 Sep;592(17):2884-2900
pubmed: 29972883
Nature. 2017 Aug 31;548(7669):543-548
pubmed: 28722012
J Vis Exp. 2010 Jul 02;(41):
pubmed: 20644507
Biochemistry. 2013 Apr 16;52(15):2518-25
pubmed: 23560983
Wiley Interdiscip Rev RNA. 2012 Mar-Apr;3(2):159-77
pubmed: 22213601
J Biol Chem. 2011 Dec 16;286(50):43134-43
pubmed: 22045815
Nature. 2007 Jun 28;447(7148):1130-4
pubmed: 17554337
Nat Chem Biol. 2015 Feb;11(2):107-14
pubmed: 25531890

Auteurs

Christian Berk (C)

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland.

Yuluan Wang (Y)

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland.

Artur Laski (A)

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland.

Stylianos Tsagkris (S)

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland.

Jonathan Hall (J)

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH